Detalhe da pesquisa
1.
Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study.
Diabetes Obes Metab
; 25(6): 1750-1757, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36843558
2.
Use of Guideline-Recommended Risk Reduction Strategies Among Patients With Diabetes and Atherosclerotic Cardiovascular Disease.
Circulation
; 140(7): 618-620, 2019 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31174429
3.
Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD).
Clin Cardiol
; 45(12): 1303-1310, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124341
4.
Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US.
JAMA Cardiol
; 2021 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34132735
5.
What Do US Physicians and Patients Think About Lipid-Lowering Therapy and Goals of Treatment? Results From the GOULD Registry.
J Am Heart Assoc
; 10(16): e020893, 2021 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34369165